Aandeel EMH EMERALD HEALTH THERAPEUTICS
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Emerald Health Therapeutics

Aandelen

EMH

CA29102R1064

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!
Gratis inschrijven
C3 Souvenir Holding, Inc. completed the acquisition of Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc.
C3 Souvenir Holding, Inc. entered into a share purchase agreement to acquire Verdelite Sciences, Inc. from Emerald Health Therapeutics, Inc. for CAD 12 million.
CSE Bulletin: Delist - Emerald Health Therapeutics, Inc. (EMH)
Skye Bioscience, Inc. completed the acquisition of Emerald Health Therapeutics, Inc. from Emerald Health Sciences Inc. and others.
IIROC Trading Halt - EMH
Emerald Health Therapeutics Announces Bridge Loan to Skye Bioscience and Provides Update on Merger
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Emerald Health Therapeutics Receives Court Approval of Plan of Arrangement with Skye Bioscience
Skye Bioscience Reports that CSE-listed Emerald Health Therapeutics Shareholders Voted in Favor of Plan of Arrangement
Certain Emerald Health Shareholders Oppose Proposed Merger with Skye Biosciences
Group of Shareholders Oppose Plan of Arrangement Between Emerald Health Therapeutics and Skye Biosciences Inc.
Emerald Health Therapeutics Announces Revocation of Management Cease Trade Order
Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results
Emerald Health Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Emerald Health Therapeutics : 2021 Q4
Emerald Health Therapeutics : 2021 - Audited Financial Statements
Emerald Health Therapeutics, Inc. - Reports 2021 Year-end Results and Corporate Update
Emerald Health Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Emerald Health Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
Skye Bioscience, Inc. entered into term sheet to acquire Emerald Health Therapeutics, Inc. from Emerald Health Sciences Inc. and others for CAD 24.4 million.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers EMH
  4. Nieuws Emerald Health Therapeutics
  5. Andere talen